Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2014

01.06.2014 | Original Article

Final adult height in kidney recipients who underwent highly successful transplantation as children: a single-center experience

verfasst von: Hiroshi Fujii, Hiroko Chikamoto, Yuko Akioka, Motoshi Hattori

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Achieving a normal final adult height (FH) remains a challenge in the field of pediatric kidney transplantation (KTx). To examine the optimal approach to assuring normal FH following KTx, we retrospectively examined the post-transplant growth and FH of pediatric KTx recipients.

Methods

Since the relevant factors affecting the FH of children following KTx are multifactorial and notably complex, KTx recipients with persistent good graft function and successful steroid minimization until FH attainment were selected for this study.

Results

Thirteen patients were enrolled in this study. The mean estimated glomerular filtration rate was 72.1 ± 15.3 ml/min/1.73 m2, and the mean corticosteroid dose was 0.05 ± 0.05 mg/kg on alternate days at the time of FH attainment. Despite highly successful KTx, four (30.8 %) patients (one who underwent KTx before puberty and three during puberty) showed a decrease in the height standard deviation score (hSDS) from the time of KTx until FH attainment. Moreover, of these, two male patients had an FH with an SD <−2.

Conclusion

FH remained suboptimal despite highly successful KTx. Not only highly successful KTx but also further treatment such as steroid avoidance, early steroid withdrawal or using rhGH might be necessary to assure a normal FH in some pubertal patients.
Literatur
2.
Zurück zum Zitat Broyer M, Le Bihan C, Charbit M, Guest G, Tête MJ, Gagnadoux MF, Niaudet P. Long-term social outcome of children after kidney transplantation. Transplantation. 2004;77:1033–7.PubMedCrossRef Broyer M, Le Bihan C, Charbit M, Guest G, Tête MJ, Gagnadoux MF, Niaudet P. Long-term social outcome of children after kidney transplantation. Transplantation. 2004;77:1033–7.PubMedCrossRef
3.
Zurück zum Zitat Fine RN. Management of growth retardation in pediatric recipients of renal allografts. Nat Clin Pract Nephrol. 2007;3:318–24.PubMedCrossRef Fine RN. Management of growth retardation in pediatric recipients of renal allografts. Nat Clin Pract Nephrol. 2007;3:318–24.PubMedCrossRef
4.
Zurück zum Zitat Cochat P, Harambat J. Maximizing growth in children after renal transplantation. Transplantation. 2009;88:1321–2.PubMedCrossRef Cochat P, Harambat J. Maximizing growth in children after renal transplantation. Transplantation. 2009;88:1321–2.PubMedCrossRef
5.
Zurück zum Zitat Hokken-Koelega AC, van Zaal MA, van Bergen W, de Ridder MA, Stijnen T, Wolff ED, de Jong RC, Donckerwolcke RA, de Muinck Keizer-Schrama SM, Drop SL. Final height and its predictive factors after renal transplantation in childhood. Pediatr Res. 1994;36:323–8.PubMedCrossRef Hokken-Koelega AC, van Zaal MA, van Bergen W, de Ridder MA, Stijnen T, Wolff ED, de Jong RC, Donckerwolcke RA, de Muinck Keizer-Schrama SM, Drop SL. Final height and its predictive factors after renal transplantation in childhood. Pediatr Res. 1994;36:323–8.PubMedCrossRef
6.
Zurück zum Zitat Broyer M, Guest G, Gagnadoux MF. Growth rate in children receiving alternate day corticosteroid treatment after kidney transplantation. J Pediatr. 1992;120:721–5.PubMedCrossRef Broyer M, Guest G, Gagnadoux MF. Growth rate in children receiving alternate day corticosteroid treatment after kidney transplantation. J Pediatr. 1992;120:721–5.PubMedCrossRef
7.
Zurück zum Zitat Fine RN, Martz K, Stablein D. What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? Pediatr Nephrol. 2010;25:739–46.PubMedCrossRef Fine RN, Martz K, Stablein D. What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? Pediatr Nephrol. 2010;25:739–46.PubMedCrossRef
8.
Zurück zum Zitat Nissel R, Brázda I, Feneberg R, Wigger M, Greiner C, Querfeld U, Haffner D. Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int. 2004;66:792–800.PubMedCrossRef Nissel R, Brázda I, Feneberg R, Wigger M, Greiner C, Querfeld U, Haffner D. Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int. 2004;66:792–800.PubMedCrossRef
9.
Zurück zum Zitat Hattori M, Akioka Y, Chikamoto H, Kobayashi N, Tsuchiya K, Shimizu M, Kagami S, Tsukaguchi H. Increase of integrin-linked kinase activity in cultured podocytes upon stimulation with plasma from patients with recurrent FSGS. Am J Transplant. 2008;8:1550–6.PubMedCrossRef Hattori M, Akioka Y, Chikamoto H, Kobayashi N, Tsuchiya K, Shimizu M, Kagami S, Tsukaguchi H. Increase of integrin-linked kinase activity in cultured podocytes upon stimulation with plasma from patients with recurrent FSGS. Am J Transplant. 2008;8:1550–6.PubMedCrossRef
10.
Zurück zum Zitat Suwa S, Tachibana K, Maesaka H, Tanaka T, Yokoya S. Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol. 1992;1:5–13.CrossRef Suwa S, Tachibana K, Maesaka H, Tanaka T, Yokoya S. Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol. 1992;1:5–13.CrossRef
11.
Zurück zum Zitat Murata M. Japanese specific bone age standard on the TW 2. Clin Pediatr Endocrinol. 1993;2(Suppl 3):35–41.CrossRef Murata M. Japanese specific bone age standard on the TW 2. Clin Pediatr Endocrinol. 1993;2(Suppl 3):35–41.CrossRef
12.
Zurück zum Zitat Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571–90.PubMed Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571–90.PubMed
13.
Zurück zum Zitat Fine RN. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol. 2010;25:725–32.PubMedCrossRef Fine RN. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol. 2010;25:725–32.PubMedCrossRef
14.
Zurück zum Zitat Englund MS, Tydén G, Wikstad I, Berg UB. Growth impairment at renal transplantation: a determinant of growth and final height. Pediatr Transplant. 2003;7:192–9.PubMedCrossRef Englund MS, Tydén G, Wikstad I, Berg UB. Growth impairment at renal transplantation: a determinant of growth and final height. Pediatr Transplant. 2003;7:192–9.PubMedCrossRef
15.
Zurück zum Zitat Schaefer F, Seidel C, Binding A, Gasser T, Largo RH, Prader A, Schärer K. Pubertal growth in chronic renal failure. Pediatr Res. 1990;28:5–10.PubMedCrossRef Schaefer F, Seidel C, Binding A, Gasser T, Largo RH, Prader A, Schärer K. Pubertal growth in chronic renal failure. Pediatr Res. 1990;28:5–10.PubMedCrossRef
16.
Zurück zum Zitat Maxwell H, Haffner D, Rees L. Catch-up growth occurs after renal transplantation in children of pubertal age. J Pediatr. 1998;133:435–44.PubMedCrossRef Maxwell H, Haffner D, Rees L. Catch-up growth occurs after renal transplantation in children of pubertal age. J Pediatr. 1998;133:435–44.PubMedCrossRef
17.
Zurück zum Zitat Klare B, Montoya CR, Fisher DC, Stangl MJ, Haffner D. Normal adult height after steroid-withdrawal within 6 months of pediatric kidney transplantation: a 20 years single center experience. Transplant Int. 2012;25:276–82.CrossRef Klare B, Montoya CR, Fisher DC, Stangl MJ, Haffner D. Normal adult height after steroid-withdrawal within 6 months of pediatric kidney transplantation: a 20 years single center experience. Transplant Int. 2012;25:276–82.CrossRef
18.
Zurück zum Zitat Delucchi Á, Valenzuela M, Lillo AM, Guerrero JL, Cano F, Azocar M, Zambrano P, Salas P, Pinto V, Ferrario M, Rodriguez J, Cavada G. Early steroid withdrawal in pediatric renal transplant: five years of follow-up. Pediatr Nephrol. 2011;26:2235–44.PubMedCrossRef Delucchi Á, Valenzuela M, Lillo AM, Guerrero JL, Cano F, Azocar M, Zambrano P, Salas P, Pinto V, Ferrario M, Rodriguez J, Cavada G. Early steroid withdrawal in pediatric renal transplant: five years of follow-up. Pediatr Nephrol. 2011;26:2235–44.PubMedCrossRef
19.
Zurück zum Zitat Grenda R, Watoson A, Trompeter R, Tönshoff B, Jaray J, Fitzpatrick M, Murer L, Vondrak K, Maxwell H, van Damme -Lombaerts R, Loirat C, Mor E, Cochat P, Milford DV, Brown M, Webb NJ. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: The TWIST study. Am J Transplant. 2010;10:828–36. Grenda R, Watoson A, Trompeter R, Tönshoff B, Jaray J, Fitzpatrick M, Murer L, Vondrak K, Maxwell H, van Damme -Lombaerts R, Loirat C, Mor E, Cochat P, Milford DV, Brown M, Webb NJ. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: The TWIST study. Am J Transplant. 2010;10:828–36.
20.
Zurück zum Zitat Li L, Chang A, Naesens M, Kambham N, Waskerwitz J, Martin J, Wong C, Alexander S, Grimm P, Concepcion W, Salvatierra O, Sarwal MM. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patients benefits. Am J Transplant. 2009;9:1362–72.PubMedCentralPubMedCrossRef Li L, Chang A, Naesens M, Kambham N, Waskerwitz J, Martin J, Wong C, Alexander S, Grimm P, Concepcion W, Salvatierra O, Sarwal MM. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patients benefits. Am J Transplant. 2009;9:1362–72.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Grenda R. Effects of steroid avoidance and novel protocols on growth in paediatric renal transplant patients. Pediatr Nephrol. 2010;25:747–52.PubMedCrossRef Grenda R. Effects of steroid avoidance and novel protocols on growth in paediatric renal transplant patients. Pediatr Nephrol. 2010;25:747–52.PubMedCrossRef
22.
Zurück zum Zitat Höcker B, Weber LT, Feneberg R, Drube J, John U, Fehrenbach H, Pohl M, Zimmering M, Fründ S, Klaus G, Wühl E, Tönshoff B. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine micro emulsion and mycophenolate mofetil. Transplantation. 2009;87:934–41.PubMedCrossRef Höcker B, Weber LT, Feneberg R, Drube J, John U, Fehrenbach H, Pohl M, Zimmering M, Fründ S, Klaus G, Wühl E, Tönshoff B. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine micro emulsion and mycophenolate mofetil. Transplantation. 2009;87:934–41.PubMedCrossRef
23.
Zurück zum Zitat Motoyama O, Hasegawa A, Aikawa A, Shishido S, Honda M, Tsuzuki K, Kinukawa T, Hattori M, Ogawa O, Yanagihara T, Saito K, Takahashi K, Oshima S. Final height in a prospective trial of late steroid withdrawal after pediatric renal transplantation treated with cyclosporine and mizoribine. Pediatr Transplant. 2012;16:78–82.PubMedCrossRef Motoyama O, Hasegawa A, Aikawa A, Shishido S, Honda M, Tsuzuki K, Kinukawa T, Hattori M, Ogawa O, Yanagihara T, Saito K, Takahashi K, Oshima S. Final height in a prospective trial of late steroid withdrawal after pediatric renal transplantation treated with cyclosporine and mizoribine. Pediatr Transplant. 2012;16:78–82.PubMedCrossRef
24.
Zurück zum Zitat Tainio J, Qvist E, Vehmas R, Jahnukainen K, Hölttä T, Valta H, Jahnukainen T, Jalanko H. Pubertal development is normal in adolescents after renal transplantation in childhood. Transplantation. 2011;92:404–9.PubMedCrossRef Tainio J, Qvist E, Vehmas R, Jahnukainen K, Hölttä T, Valta H, Jahnukainen T, Jalanko H. Pubertal development is normal in adolescents after renal transplantation in childhood. Transplantation. 2011;92:404–9.PubMedCrossRef
25.
Zurück zum Zitat Hokken-Koelega AC, Stijnen T, de Ridder MA, de Muinck Keizer-Schrama SM, Wolff ED, de Jong MC, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SL. Growth hormone treatment in growth-retarded adolescents after renal transplantation. Lancet. 1994;343:1313–7.PubMedCrossRef Hokken-Koelega AC, Stijnen T, de Ridder MA, de Muinck Keizer-Schrama SM, Wolff ED, de Jong MC, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SL. Growth hormone treatment in growth-retarded adolescents after renal transplantation. Lancet. 1994;343:1313–7.PubMedCrossRef
Metadaten
Titel
Final adult height in kidney recipients who underwent highly successful transplantation as children: a single-center experience
verfasst von
Hiroshi Fujii
Hiroko Chikamoto
Yuko Akioka
Motoshi Hattori
Publikationsdatum
01.06.2014
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2014
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0842-4

Weitere Artikel der Ausgabe 3/2014

Clinical and Experimental Nephrology 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.